Search
for
Sort by
Research 30 of 103
- Wide range applications of botulinum toxin in medicine - literature review
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Periorbital Reconstruction in Facial Paralysis
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- The Aging Face
- Rejuvenation of the Male Brow
- Cytostatics and immunosuppressive drugs
- Renal tubular dysfunction presenting as recurrent hypokalemic periodic quadriparesis in systemic lupus erythematosus
- Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review
- E-Poster
- Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
- Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
- Alopecia and Associated Toxic Agents: A Systematic Review
- Epidemiology of Cosmetic Procedures: An Update for Dermatologists
- A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds
- The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin
- Floppy Iris Syndrome
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Vitamin D-dependent Rickets Type II
- The Neurobiology of Sexual Function
- Severe cutaneous adverse reactions to drugs
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Secondary cicatricial and other permanent alopecias
- Skin diseases in consequence of endocrine alterations
- Alopecia Areata
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target